Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis.
Longshaw C, Santerre Henriksen A, Dressel D, Malysa M, Silvestri C, Takemura M, Yamano Y, Baba T, Slover CM. Longshaw C, et al. Among authors: santerre henriksen a. Microbiol Spectr. 2023 Dec 12;11(6):e0237123. doi: 10.1128/spectrum.02371-23. Epub 2023 Nov 15. Microbiol Spectr. 2023. PMID: 37966262 Free PMC article.
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Jeannot K, Oliver A, Perry JD, Pletz MW, Stefani S, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Microbiol Spectr. 2024 Apr 2;12(4):e0383623. doi: 10.1128/spectrum.03836-23. Epub 2024 Mar 14. Microbiol Spectr. 2024. PMID: 38483164 Free PMC article.
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Arena F, Attwood M, Canton R, Gatermann S, Naas T, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Microbiol Spectr. 2024 Jun 21;12(8):e0418123. doi: 10.1128/spectrum.04181-23. Online ahead of print. Microbiol Spectr. 2024. PMID: 38904361 Free PMC article.
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW. Andes DR, et al. Among authors: santerre henriksen a. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01634-18. doi: 10.1128/AAC.01634-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30373791 Free PMC article. Clinical Trial.
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
Antonelli A, Giani T, Coppi M, Di Pilato V, Arena F, Colavecchio OL, Conte V, Santerre Henriksen A, Rossolini GM; MRSA-HAP Study Group. Antonelli A, et al. Among authors: santerre henriksen a. J Antimicrob Chemother. 2019 Dec 1;74(12):3453-3461. doi: 10.1093/jac/dkz371. J Antimicrob Chemother. 2019. PMID: 31652323
19 results